Clinical Trials - Phase III

Found 21,407 articles

• DOR BioPharma, Inc. Reports Positive New Survival Findings From Previously Completed Phase II And III Clinical Trials Of orBec(R)

  1/20/2006

• Gentium S.p.A. Initiates Phase II/III Pediatric Trial With Defibrotide To Prevent Veno-Occlusive Disease

  1/20/2006

• Dynavax Technologies Corporation Says Allergy Drug Meets Goal Of Phase 2/3 Trial

  1/19/2006

• Novartis Corporation New Phase III Data With SPP100 Reconfirms Strong Efficacy And Excellent Safety Profile As Monotherapy And Co-Administration Therapy For Treatment Of Hypertension

  1/19/2006

• GTx, Inc. To Continue With Pivotal Studies Of Acapodene

  1/19/2006

• Genentech, Inc. Release: Preliminary Phase III Data From Head-To-Head Study Of Lucentis Shows Lucentis Improved Vision Compared To Visudyne In Patients With Wet Age-Related Macular Degeneration

  1/16/2006

• Nuvo Research Inc. Reports Detailed Phase III Pennsaid(R) Clinical Results

  1/16/2006

• Ark Therapeutics Says Vitor Study Confirms Therapeutic Effect In Cancer Cachexia

  1/16/2006

• FDA Asks Genelabs Technologies, Inc. For Additional Trial Of Lupus Drug

  1/13/2006

• InSite Vision Completes Enrollment In Second Phase 3 AzaSite(TM) Clinical Study

  1/13/2006

• Favrille, Inc. Receives FDA Fast Track Designation For FavId, Lead Product Candidate For Follicular B-Cell Non-Hodgkin's Lymphoma; Stocks Soar

  1/12/2006

• La Jolla Pharmaceutical Company To Initiate Multi-Dose Study Of Riquent In Lupus Patients

  1/11/2006

• Salix Pharmaceuticals, Ltd. Development Update; XIFAXAN(R) Trials Initiated In C. difficile-Associated Diarrhea, Irritable Bowel Syndrome And Hepatic Encephalopathy

  1/11/2006

• Rockwell Medical Technologies Finalizes Proprietary Iron-Delivery Product Phase III Clinical Trial Protocol For FDA Submission; Commences Non-Clinical Development Program

  1/11/2006

• Adherex Technologies Inc. Announces Corporate Goals For 2006

  1/11/2006

• Inspire Pharmaceuticals Announces European Orphan Drug Designation For Denufosol Tetrasodium For Treatment Of Cystic Fibrosis

  1/10/2006

• Spherix Chooses ENVIRON To Assist With Diabetes Clinical Trial

  1/10/2006

• Celgene Corporation THALOMID(R) Pivotal Phase III Multiple Myeloma Trial Reaches Pre-Specified Interim Endpoint; Trial Stopped Early

  1/9/2006

• Protein Sciences Announces Closing Of $6 Million Financing And Partnership In Diabetes Vaccine

  1/9/2006

• Zonagen Receives IRB Approval to Commence Phase III Study Of Androxal(TM) For The Treatment Of Testosterone Deficiency

  1/9/2006